Table 2.
Comparison of retinal layers between patients recovered from COVID-19 infection in early period and at 12 months and healthy subjects
| V1 visit (n = 27) | V2 visit (n = 27) | Healthy controls (n = 27) | V1 vs. V2 p valueꞎ | V1 vs. control pvalueꞎꞎ | V2 vs. control pvalueꞎꞎ | |
|---|---|---|---|---|---|---|
| Retina (μm, mean ± SD) | ||||||
| Central | 270.26 ± 19.55 | 271.87 ± 24.71 | 276.30 ± 19.55 | 0.364 | 0.102 | 0.295 | 
| Inner ring | 337.05 ± 13.83 | 337.04 ± 15.03 | 343.98 ± 14.51 | 0.990 | 0.013* | 0.016 | 
| Outer ring | 306.17 ± 10.42 | 305.49 ± 11.85 | 310.89 ± 11.05 | 0.090 | 0.024* | 0.016 | 
| mRNFL (μm, mean ± SD) | ||||||
| Central | 12.38 ± 2.54 | 11.98 ± 2.43 | 12.61 ± 1.82 | 0.094 | 0.603 | 0.132 | 
| Inner ring | 21.89 ± 1.84 | 21.70 ± 2.30 | 22.45 ± 2.34 | 0.304 | 0.174 | 0.097 | 
| Outer ring | 35.55 ± 4.04 | 34.70 ± 4.47 | 37.21 ± 4.60 | 0.041* | 0.049* | 0.005* | 
| GCIPL (μm, mean ± SD) | ||||||
| Central | 38.04 ± 10.62 | 37.70 ± 11.57 | 39.52 ± 8.92 | 0.733 | 0.434 | 0.364 | 
| Inner ring | 90.91 ± 7.90 | 91.72 ± 7.97 | 94.16 ± 5.43 | 0.166 | 0.015* | 0.067 | 
| Outer ring | 69.99 ± 5.55 | 70.45 ± 5.27 | 70.84 ± 4.40 | 0.283 | 0.382 | 0.682 | 
| INL (μm, mean ± SD) | ||||||
| Central | 20.43 ± 6.61 | 20.67 ± 6,51 | 20.46 ± 4.84 | 0.687 | 0.754 | 0.837 | 
| Inner ring | 40.06 ± 2.99 | 40.02 ± 3.40 | 39.57 ± 2.66 | 0.914 | 0.370 | 0.442 | 
| Outer ring | 34.97 ± 1.88 | 35.07 ± 2.16 | 34.88 ± 1.89 | 0.595 | 0.810 | 0.629 | 
| OPL (μm, mean ± SD) | ||||||
| Central | 27.46 ± 7.30 | 25.59 ± 6.45 | 25.20 ± 5.16 | 0.102 | 0.067 | 0.730 | 
| Inner ring | 32.88 ± 3.08 | 33.07 ± 4.05 | 32.05 ± 3.38 | 0.663 | 0.184 | 0.158 | 
| Outer ring | 28.50 ± 2.08 | 27.97 ± 1.77 | 28.00 ± 2.39 | 0.041 | 0.254 | 0.927 | 
| ONL (μm, mean ± SD) | ||||||
| Central | 87.39 ± 11.89 | 88.46 ± 11.53 | 92.15 ± 11.69 | 0.472 | 0.038* | 0.102 | 
| Inner ring | 69.67 ± 7.51 | 68.78 ± 8.07 | 74.13 ± 8.81 | 0.182 | 0.006* | 0.001* | 
| Outer ring | 59.02 ± 7.64 | 58.74 ± 7.00 | 61.21 ± 6.76 | 0.591 | 0.118 | 0.065 | 
| pRNFL (μm, mean ± SD) | ||||||
| Central | 99.07 ± 8.06 | 98.87 ± 9.25 | 106.72 ± 14.29 | 0.752 | 0.001* | 0.001* | 
| Superotemporal | 133.69 ± 20.33 | 135.15 ± 19.49 | 137.72 ± 17.33 | 0.305 | 0.269 | 0.470 | 
| Superonasal | 110.30 ± 19.99 | 110.78 ± 19.99 | 115.59 ± 19.18 | 0.759 | 0.163 | 0.204 | 
| Nasal | 70.96 ± 14.30 | 71.17 ± 12.99 | 75.04 ± 15.76 | 0.869 | 0.162 | 0.167 | 
| Inferonasal | 112.19 ± 16.31 | 110.37 ± 16.46 | 120.39 ± 20.58 | 0.132 | 0.024* | 0.006* | 
| Inferotemporal | 149.65 ± 21.64 | 148.39 ± 20.47 | 154.15 ± 15.87 | 0.361 | 0.221 | 0.105 | 
| Temporal | 71.91 ± 11.15 | 72.13 ± 12.70 | 75.78 ± 11.46 | 0.805 | 0.078 | 0.120 | 
GCIPL ganglion cell-inner plexiform layer, INL inner nuclear layer, mRNFL macular retinal nerve fiber layer, ONL outer nuclear layer, OPL outer plexiform layer, pRNFL peripapillary retinal nerve fiber layer
ꞎPaired t test
ꞎꞎIndependent t test
* p < 0.05